Table 2. Statistical Analysis of EAE-like symptoms after Immunisation with MOG and MSRV-Env complete in C57BL/6 mice.

Group Treatment	Day of Onset +/− SD	p value Time to onset	MMS +/− SD	p value MMS	% body weight at end of experiment +/− SD	p value body weight	Died during study
No Env	37.0+/−7.1		0.92+/−1.24		120.1+/−8.3		0/6
Env 20 µg	31.7+/−4.0	0,0078*	2.25+/−0.94	0,0581	110.2+/−8.5	0,0339*	0/6
Env 50 µg	29.2+/−3.6	0,0198*	2.92+/−1.69	0,0398*	101.7+/−18.9	0,0323*	1/6

Data correspond to those illustrated in figure 4C. Time to onset was compared using Wilcoxon's survival test; MMSs were compared using Wilcoxon's non-parametric test; Change in body weight at the end of the study was compared using Student's t-test.

^* Statistically significant value.